financetom
Business
financetom
/
Business
/
Salesforce Growth Recovery Prospects Remain Unclear Despite Fairly In Line Q2 Results, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Salesforce Growth Recovery Prospects Remain Unclear Despite Fairly In Line Q2 Results, UBS Says
Aug 31, 2024 8:05 PM

01:13 PM EDT, 08/29/2024 (MT Newswires) -- Salesforce's ( CRM ) fiscal Q2 results were generally in line, but its growth recovery prospects remain clouded, UBS said in a report sent Thursday.

"The in-line results may come as a modest relief, but the cautious H2 growth outlook and the Workday revs guide-down don't point to an all-clear event for Software investors just yet," the investment firm said.

The software company is looking at a 7% revenue growth in fiscal Q3, but unless it can deliver a solid beat in the ongoing quarter, its growth in Q4 needs to be 8% to reach mid-point of full-year revenue guide, or 9% to hit the high-end of the range, the brokerage said.

However, Salesforce ( CRM ) "appears to be signaling the strong potential to hit the midlow end, which doesn't require a Q4 acceleration." At the same time however, it said "the company is citing 2H pressure in y/y growth from pro services revs and the MuleSoft/Tableau segment."

UBS said the departure of Salesforce's ( CRM ) "very well-liked" CFO Amy Weaver was disappointing, but "not a negative read-through to the company."

UBS raised the price target for Salesforce ( CRM ) to $275 from $250, while reiterating neutral rating.

Price: 259.30, Change: +0.40, Percent Change: +0.15

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved